indolactam v has been researched along with teleocidin b-4 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Ichinose, T; Itai, A; Kawai, T; Shudo, K | 1 |
| Driedger, PE; Endo, Y; Itai, A; Mizutani, MY; Ohno, M; Shudo, K; Stabel, S; Takehana, S; Tomioka, N | 1 |
| Hagiwara, N; Hayashi, H; Irie, K; Ito, Y; Koshimizu, K; Murao, S; Tokuda, H | 1 |
| Endo, Y; Fujiki, H; Itai, A; Shudo, K | 1 |
| Hagiwara, N; Irie, K; Koshimizu, K; Tokuda, H | 1 |
| Endo, Y; Fujiki, H; Hasegawa, M; Hirota, M; Horiuchi, T; Nakayasu, M; Shudo, K; Suganuma, M; Yoshizawa, S | 1 |
| Hiragun, A; Sato, M; Shudo, K | 1 |
| Acs, P; Ahmad, S; Blumberg, PM; Bogi, K; Glazer, RI; Kozikowski, AP; Lewin, NE; Ma, D; Modarres, S; Wang, S; Yao, J | 1 |
| Bhattacharrya, D; Blumberg, PM; Kozikowski, AP; Lewin, NE; Liu, M; Lorenzo, PS; Qiao, L; Wang, S | 1 |
| Endo, Y; Fukasawa, H; Hashimoto, Y; Shudo, K; Yamaguchi, M | 1 |
| Neudörfl, JM; Schmalz, HG; Sperlich, J; Stahn, S; Stein, J; Teusch, N | 1 |
| Abe, I; Mori, T; Morita, I | 1 |
1 review(s) available for indolactam v and teleocidin b-4
| Article | Year |
|---|---|
Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis.
Topics: Animals; Cyclization; Cytochrome P-450 Enzyme System; Humans; Indoles; Lactams; Lyngbya Toxins | 2021 |
11 other study(ies) available for indolactam v and teleocidin b-4
| Article | Year |
|---|---|
Active conformation of a tumor promoter, teleocidin. A molecular dynamics study.
Topics: Carcinogens; Crystallization; Lyngbya Toxins; Magnetic Resonance Spectroscopy; Molecular Conformation; Thermodynamics | 1992 |
Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
Topics: Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Cell Division; Cysteine; Enzyme Activation; HL-60 Cells; Humans; Hydrogen Bonding; Lyngbya Toxins; Models, Molecular; Molecular Mimicry; Monocytes; Protein Binding; Protein Kinase C; Structure-Activity Relationship; Tetrahydronaphthalenes | 1998 |
Structure-activity relationship in the induction of Epstein-Barr virus by teleocidin derivatives.
Topics: Antigens, Viral; Cell Line; Dose-Response Relationship, Drug; Herpesvirus 4, Human; Humans; Indoles; Lactams; Lyngbya Toxins; Structure-Activity Relationship; Virus Replication | 1985 |
[The active structure of tumor promoters].
Topics: Carcinogens; Indoles; Lactams; Lyngbya Toxins; Protein Kinase C; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1986 |
The metabolism of indole alkaloid tumor promoter, (-)-indolactam V, which has the fundamental structure of teleocidins, by rat liver microsomes.
Topics: Animals; Antigens, Viral; Carcinogens; In Vitro Techniques; Indoles; Lactams; Lyngbya Toxins; Male; Microsomes, Liver; Mixed Function Oxygenases; Phenobarbital; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tritium | 1987 |
Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Topics: Animals; Cell Adhesion; Cell Line; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Indoles; Lactams; Leukemia, Myeloid, Acute; Lyngbya Toxins; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Protein Kinase C; Skin; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 1987 |
Effects of synthetic analogues of teleocidin, indolactam-V, on the differentiation of murine pre-adipose cells.
Topics: Adipose Tissue; Animals; Cell Differentiation; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Indoles; Lactams; Lyngbya Toxins; Mice; Stereoisomerism; Structure-Activity Relationship | 1985 |
Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivit
Topics: Antineoplastic Agents; Binding Sites; Binding, Competitive; Breast Neoplasms; Cell Division; Crystallography, X-Ray; Enzyme Inhibitors; Female; Humans; Hydrogen Bonding; Indoles; Isoenzymes; Lactams; Lyngbya Toxins; Models, Molecular; Molecular Conformation; Molecular Structure; Mutagenesis, Site-Directed; Protein Kinase C; Tumor Cells, Cultured | 1997 |
Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.
Topics: Animals; Binding Sites; Computer Simulation; Drug Design; Hydrogen Bonding; Indoles; Lactams; Lyngbya Toxins; Models, Molecular; Molecular Conformation; Mutagenesis, Site-Directed; Phorbol Esters; Protein Binding; Protein Kinase C; Structure-Activity Relationship | 1999 |
Enhancing effect of tumor promoters, phorbol esters and teleocidins on nuclear receptor-mediated transcription.
Topics: Animals; Carcinogens; Chlorocebus aethiops; COS Cells; Gene Expression Regulation; Genes, Reporter; Humans; Indoles; Lactams; Luciferases; Lyngbya Toxins; Nuclear Receptor Subfamily 1, Group F, Member 1; Okadaic Acid; Plasmids; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Retinoic Acid Receptor alpha; Tetradecanoylphorbol Acetate; Thapsigargin; Thymidine Kinase; Trans-Activators; Transcription, Genetic; Transfection | 2000 |
Synthetic Indolactam V Analogues as Inhibitors of PAR2-Induced Calcium Mobilization in Triple-Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; Calcium; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Indoles; Lactams; Lyngbya Toxins; Molecular Structure; Protein Kinase C; Receptor, PAR-2; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2018 |